Kathryn Fitch, RN, MEd

Articles by Kathryn Fitch, RN, MEd

Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL

ByKathryn Fitch, RN, MEd,Michael Kolodziej, MD, FACP

March 10th 2022

The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged 50 to 64

ByKathryn Fitch, RN, MEd,Bruce Pyenson, FSA, MAAA,Helen Blumen, MD, MBA,Thomas Weisman, MD, MBA,Art Small, MD

August 5th 2015

Screening commercially insured individuals for colorectal cancer is a high-value service, costing less per year of life saved than breast or cervical cancer screening.

Latest Updated Articles

Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL
March 10th 2022
The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged 50 to 64
August 5th 2015

Kathryn Fitch, RN, MEd

Articles by Kathryn Fitch, RN, MEd

Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL

The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged 50 to 64

Latest Updated Articles

Trending on AJMC

Lymphoma Outcomes Hinge on Oncology, Not Viral Load In People With HIV

Medicare Drug Price Negotiations Yield Uneven Out-of-Pocket Savings

New Mechanism of DME Treatment Highlights Clinical Trial Updates

Using Complement Inhibitors in GA Comes With Pros and Cons

A New Mechanism for DME in the BRUNELLO Trial: Donald J. D’Amico, MD